Treace Medical Financials
TMCI Stock | USD 9.61 0.02 0.21% |
Treace |
Treace Medical Stock Summary
Treace Medical competes with Rxsight, Axogen, Pulmonx Corp, Orthofix Medical, and Orthopediatrics Corp. Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida. Treace Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 248 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US89455T1097 |
CUSIP | 89455T109 |
Location | Florida; U.S.A |
Business Address | 100 Palmetto Park |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.treace.com |
Phone | 904 373 5940 |
Currency | USD - US Dollar |
Treace Medical Key Financial Ratios
Return On Equity | -0.51 | ||||
Return On Asset | -0.17 | ||||
Target Price | 10.04 | ||||
Number Of Employees | 516 | ||||
Beta | 0.76 |
Treace Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Treace Medical's current stock value. Our valuation model uses many indicators to compare Treace Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Treace Medical competition to find correlations between indicators driving Treace Medical's intrinsic value. More Info.Treace Medical Concepts is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Treace Medical's earnings, one of the primary drivers of an investment's value.Treace Medical Concepts Systematic Risk
Treace Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Treace Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Treace Medical Concepts correlated with the market. If Beta is less than 0 Treace Medical generally moves in the opposite direction as compared to the market. If Treace Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Treace Medical Concepts is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Treace Medical is generally in the same direction as the market. If Beta > 1 Treace Medical moves generally in the same direction as, but more than the movement of the benchmark.
About Treace Medical Financials
What exactly are Treace Medical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Treace Medical's income statement, its balance sheet, and the statement of cash flows. Potential Treace Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Treace Medical investors may use each financial statement separately, they are all related. The changes in Treace Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Treace Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Treace Medical Thematic Clasifications
Treace Medical Concepts is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Drugs | View |
Treace Medical February 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Treace Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Treace Medical Concepts. We use our internally-developed statistical techniques to arrive at the intrinsic value of Treace Medical Concepts based on widely used predictive technical indicators. In general, we focus on analyzing Treace Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Treace Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 2.71 | |||
Information Ratio | 0.0635 | |||
Maximum Drawdown | 18.71 | |||
Value At Risk | (4.19) | |||
Potential Upside | 8.46 |
Complementary Tools for Treace Stock analysis
When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |